Inventor
RUGGERI ROGER B
US37 patents
⚠️ This page may combine multiple inventors who share the name “RUGGERI ROGER B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
31 patentsUS6197786B1Mar 6, 2001
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER155 citations98
US6140343AOct 31, 2000
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER174 citations98
US10208019B2Feb 19, 2019
GLP-1 receptor agonists and uses thereof
PFIZER50 citations97
US6147090ANov 14, 2000
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
PFIZER114 citations97
US6310075B1Oct 30, 2001
Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
PFIZER64 citations96
US6147089ANov 14, 2000
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
PFIZER84 citations96
US6586448B1Jul 1, 2003
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER61 citations95
US6489478B1Dec 3, 2002
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER70 citations95
US6140342AOct 31, 2000
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
PFIZER52 citations94
US11512070B2Nov 29, 2022
GLP-1 receptor agonists and uses thereof
PFIZER11 citations93
US10851081B2Dec 1, 2020
GLP-1 receptor agonists and uses thereof
PFIZER12 citations93
US10669259B2Jun 2, 2020
GLP-1 receptor agonists and uses thereof
PFIZER13 citations93
US6395751B1May 28, 2002
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
PFIZER40 citations92
US6362198B1Mar 26, 2002
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
PFIZER36 citations91
US10934279B2Mar 2, 2021
GLP-1 receptor agonists and uses thereof
PFIZER9 citations85
US8841314B2Sep 23, 2014
2-Thiopyrimidinones
PFIZER4 citations84
US10683281B2Jun 16, 2020
GLP-1 receptor agonists and uses thereof
PFIZER8 citations83
US10676465B2Jun 9, 2020
GLP-1 receptor agonists and uses thereof
PFIZER8 citations83
US6906082B2Jun 14, 2005
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
PFIZER15 citations83
US12378230B2Aug 5, 2025
GLP-1 receptor agonists and uses thereof
PFIZER1 citations74
US7235259B2Jun 26, 2007
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
PFIZER8 citations73
US11858916B2Jan 2, 2024
GLP-1 receptor agonists and uses thereof
PFIZER2 citations71
US6492401B1Dec 10, 2002
N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
PFIZER11 citations70
US7071210B2Jul 4, 2006
CETP inhibitors in combination with antihypertensive agents and uses thereof
PFIZER3 citations63
US12319669B2Jun 3, 2025
GLP-1 receptor agonists and uses thereof
PFIZER0 citations62
US11802121B2Oct 31, 2023
GLP-1 receptor agonists and uses thereof
PFIZER0 citations62
US12331041B2Jun 17, 2025
GLP-1 receptor agonists and uses thereof
PFIZER0 citations61
US9399626B2Jul 26, 2016
2-thiopyrimidinones
PFIZER2 citations59
US9873673B2Jan 23, 2018
2-thiopyrimidinones
PFIZER0 citations48
US7618996B2Nov 17, 2009
Diaryl ether derivatives and uses thereof
PFIZER0 citations41
US7615651B2Nov 10, 2009
Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
PFIZER0 citations34